rs144982584
Positions:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_173495.3(PTCHD1):c.657C>T(p.Asn219=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00262 in 1,210,242 control chromosomes in the GnomAD database, including 3 homozygotes. There are 1,014 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0018 ( 1 hom., 47 hem., cov: 23)
Exomes 𝑓: 0.0027 ( 2 hom. 967 hem. )
Consequence
PTCHD1
NM_173495.3 synonymous
NM_173495.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.01
Genes affected
PTCHD1 (HGNC:26392): (patched domain containing 1) This gene encodes a membrane protein with a patched domain. The encoded protein is similar to Drosophila proteins which act as receptors for the morphogen sonic hedgehog. Deletions in this gene, which is located on the X chromosome, are associated with intellectual disability and autism (PMID: 21091464, PMID: 20844286). [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant X-23379896-C-T is Benign according to our data. Variant chrX-23379896-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 195428.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.01 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 47 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTCHD1 | NM_173495.3 | c.657C>T | p.Asn219= | synonymous_variant | 2/3 | ENST00000379361.5 | NP_775766.2 | |
PTCHD1 | XM_011545449.4 | c.657C>T | p.Asn219= | synonymous_variant | 3/4 | XP_011543751.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTCHD1 | ENST00000379361.5 | c.657C>T | p.Asn219= | synonymous_variant | 2/3 | 1 | NM_173495.3 | ENSP00000368666 | P1 | |
PTCHD1 | ENST00000456522.1 | c.159-12635C>T | intron_variant | 1 | ENSP00000406663 |
Frequencies
GnomAD3 genomes AF: 0.00176 AC: 198AN: 112196Hom.: 1 Cov.: 23 AF XY: 0.00137 AC XY: 47AN XY: 34346
GnomAD3 genomes
AF:
AC:
198
AN:
112196
Hom.:
Cov.:
23
AF XY:
AC XY:
47
AN XY:
34346
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00189 AC: 347AN: 183471Hom.: 1 AF XY: 0.00199 AC XY: 135AN XY: 67901
GnomAD3 exomes
AF:
AC:
347
AN:
183471
Hom.:
AF XY:
AC XY:
135
AN XY:
67901
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00270 AC: 2966AN: 1097991Hom.: 2 Cov.: 31 AF XY: 0.00266 AC XY: 967AN XY: 363347
GnomAD4 exome
AF:
AC:
2966
AN:
1097991
Hom.:
Cov.:
31
AF XY:
AC XY:
967
AN XY:
363347
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00177 AC: 199AN: 112251Hom.: 1 Cov.: 23 AF XY: 0.00137 AC XY: 47AN XY: 34411
GnomAD4 genome
AF:
AC:
199
AN:
112251
Hom.:
Cov.:
23
AF XY:
AC XY:
47
AN XY:
34411
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 02, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 12, 2014 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 16, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 30, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at